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preceded by a thorough science based review of suitability 
and safety by an independent authority. Food safety events 
should be managed on an international basis. Global collab-
oration of food producers, food-safety authorities, paediatri-
cians and scientists is needed to efficiently exchange infor-
mation and to best protect public health. 
 Copyright © 2012 S. Karger AG, Basel 
 The interest of pediatricians, other health care profes-
sionals, and the public in infant nutrition products is of-
ten focused on possible functional effects, such as poten-
tial risk reduction of allergic disorders or the potential 
benefits for child development or long-term health  [1, 2] . 
In contrast, pediatricians and other health care profes-
sionals often assume quality and safety as a matter of 
course and do not devote the same level of attention to 
these aspects. 
 However, quality and safety issues are of key impor-
tance for infant feeding and child health. Suitability and 
safety are fundamental regulatory requirements for al-
lowing the marketing of infant food products  [3] . These 
aspects are important because infants carry particularly 
high risks for untoward effects of unbalanced diets or of 
harmful food components. Why? Because they grow rap-
idly and have high nutrient needs, and because during the 
first months after birth usually one sole milk source must 
meet all the dietary requirements. Further, immature and 
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 Abstract 
 Quality and safety aspects of infant nutrition are of key im-
portance for child health, but oftentimes they do not get 
much attention by health care professionals whose interest 
tends to focus on functional benefits of early nutrition. Un-
balanced diets and harmful food components induce par-
ticularly high risks for untoward effects in infants because of 
their rapid growth, high nutrient needs, and their typical de-
pendence on only one or few foods during the first months 
of life. The concepts, standards and practices that relate to 
infant food quality and safety were discussed at a scientific 
workshop organized by the Child Health Foundation and the 
Early Nutrition Academy jointly with the European Society 
for Paediatric Gastroenterology, Hepatology and Nutrition, 
and a summary is provided here. The participants reviewed 
past and current issues on quality and safety, the role of dif-
ferent stakeholders, and recommendations to avert future 
issues. It was concluded that a high level of quality and safe-
ty is currently achieved, but this is no reason for complacen-
cy. The food industry carries the primary responsibility for 
the safety and suitability of their products, including the 
quality of composition, raw materials and production pro-
cesses. Introduction of new or modified products should be 
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rapidly developing infants have a high susceptibility to 
harmful effects from many exposures.
 Breast-feeding is regarded as the optimal form of nu-
trition for human infants because of its numerous health 
advantages, including, for example, prevention of infec-
tious diseases, promotion of neurodevelopment, and re-
duced risk of later obesity, diabetes, and hypertension 
 [4–6] . Despite these recommendations, the vast majority 
of infants worldwide receive some infant formula at some 
time during their first year of life, whether as their sole 
source of nutrition or in combination with human milk, 
or homemade or commercial complementary foods. 
Hence, the concepts, standards, and practices that relate 
to the quality and safety of food products for infants are 
of great public health importance.
 A workshop was held in Sorrento, Italy, in May 2011, 
on behalf of the charitable Child Health Foundation, Mu-
nich (www.kindergesundheit.de) and the Early Nutrition 
Academy (www.early-nutrition.org), in collaboration 
with the European Society for Pediatric Gastroenterolo-
gy, Hepatology and Nutrition (www.espghan.org) to re-
view and discuss some of the key questions in this area. 
They specifically addressed the following questions:
 (1) What lessons have we learned from past issues of qual-
ity and safety?  
 (2) What do we agree are the current issues for quality and 
safety?  
 (3) What do we predict might be future issues for quality 
and safety and why?  
 (4) Which stakeholders should worry about current and 
future quality and safety issues (manufacturers, gov-
ernment, health professionals, others)? Why are they 
issues for them?  
 (5) What recommendations do we agree for these stake-
holder groups to improve concerning any current is-
sues and to avert any predicted future issues? 
 This report summarizes some general issues addressed 
by the workshop. It is complemented by a series of reports 
published in this issue of the journal which provide sum-
maries and key conclusions of presentations held at the 
workshop.
 Safety Issues: Nutrient Contents 
 Standards and regulations for infant formula and oth-
er infant foods aim at ensuring high levels of safety and 
are much more rigorous than regulations for other food 
products  [3, 7–9] . In fact, it was a serious safety issue that 
led to the adoption of the US Infant Formula Act in 1980. 
The issue was the change in the formulation of two soy 
infant formulae which were introduced in 1978 by a major 
infant formula manufacturer in the USA, with a marked 
reduction in the sodium chloride content. These chloride 
deficient formulations induced hypochloremic metabolic 
alkalosis and growth faltering in the babies who received 
them, and they were later also found to be associated with 
adverse long-term effects on developmental outcomes and 
with behavioral problems  [10–13] . The United States Con-
gress reviewed the matter and determined that protection 
of infants fed infant formulae needed to be improved by 
greater regulatory control over infant formula, which led 
to the US Infant Formula Act of 1980 (Pub. L 96–359). 
This act first established minimum nutrient requirements 
for infant formulae, defined adulteration and quality con-
trol procedures, and specified inspection requirements as 
well as recall procedures  [9] .
 The establishment of this and further national, region-
al, and global standards and regulations on infant formu-
lae and baby foods has contributed to the very high level 
of safety of such products that exists today. Compared to 
the enormous number of infants fed such products on a 
daily basis, only a very small number of adverse events 
has become known.
 However, in spite of established standards and regula-
tions, the occurrence of nutrient deficiency due to com-
positional errors can still occur. In 2003, a thiamine defi-
cient soy protein-based infant formula led to severe thia-
mine deficiency in recipient infants with lactic acidosis, 
encephalopathy, cardiomyopathy, and deaths  [14, 15] , 
along with long-term neurologic problems in surviving 
children  [16–18] . This tragedy apparently resulted from 
an error of the manufacturer in designing the nutrient 
composition of the formula  [19, 20] , and it calls for the ap-
plication of even more stringent quality control measures.
 Not only nutrient deficiency, but also too high nutrient 
intakes may cause adverse effects. An excessive supply of 
dietary components, and the supply of unnecessary com-
ponents, can put a burden on the infant’s metabolic and 
other functions. Dietary components that are not utilized 
or stored by the body must be excreted as such or in the 
form of metabolites, in most cases as solutes with the urine. 
However, water available to form urine is limited, and in-
fants particularly during the first months of life have a lim-
ited ability to concentrate urine. Therefore, the need to ex-
crete any additional solutes can reduce the margin of safe-
ty, particularly if the infant is stressed by fever or diarrhea.
 An impressive example of untoward effects of a too 
high nutrient intake is the observation that an additional 
daily iron intake of 1 mg/kg from 6 to 9 months of age 
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induces significantly impaired length growth in iron suf-
ficient infants  [21, 22] . Therefore, it is important to define 
not only adequate minimum but also maximum ingredi-
ent contents in infant food products  [8] .
 Adulteration 
 Probably the largest infant food safety problem ever 
occurred in 2008 in China: infant formula was produced 
from milk to which melamine had been added to sham a 
higher protein content, which caused urolithiasis and re-
lated damage in a large number of infants  [23–27] . It is 
estimated that more than 300,000 infants were exposed to 
such adulterated formula, with tens of thousands of hos-
pitalizations and 6 reported deaths  [27, 28] . This inten-
tional milk contamination with melamine had interna-
tional implications due to the global distribution of these 
products and delayed reporting. This led to exposure to 
melamine-contaminated products originating from Chi-
na, or to products containing contaminated ingredients 
from China, not only across Asia but also in Africa, Aus-
tralia/New Zealand, Europe, and North America  [25, 28] .
 Another case of adulteration became known in 2011, 
when a major incident of phthalate-contaminated food-
stuffs occurred in Taiwan. The toxic compounds di-(2-
ethylhexyl)phthalate and diisononyl phthalate were de-
liberately added to foodstuffs to substitute for an emulsi-
fier, including foods that were consumed by infants  [29] . 
Again, phthalate-contaminated products were exported 
to and found in several other countries. The supply of 
phthalate to infants is of concern, since phthalate expo-
sure in early life has been associated with endocrine dis-
rupting effects, impaired growth, mental and motor de-
velopment, and increased risk for heart defects  [30–33] .
 Microorganisms and Their Toxins 
 Food products, including powdered infant formulae, 
are not sterile but may contain viable microorganisms, 
including pathogens such as  Salmonella enterica ,  Salmo-
nella typhi ,  Shigella dysenteriae  or  Cronobacter sakazakii 
 [34–36] that can cause serious infections in infants. In 
recent years, there have been numerous recurrences of 
invasive infections with  Cronobacter sakazakii  that led to 
bacteremia, necrotizing enterocolitis and meningitis – 
predominantly in premature infants – which were related 
to the consumption of infant formula reconstituted from 
powder contaminated with these bacteria  [37–40] . Oc-
currence of invasive infections occurred after prolonged 
storage of reconstituted formula at warm temperatures 
which can lead to a marked increase in bacterial numbers 
and hence reach an infective dose  [41, 42] . Reij et al.  [43] 
 recently estimated the burden of disease of  Cronobacter 
infections in infants to the Dutch population as 19–24 
disability-adjusted life years (DALYs) per year, of which 
95% are due to meningitis. Based on these estimates, 
Cronobacter infections represent 0.5–2.4% of the total es-
timated burden of foodborne infections and intoxica-
tions and would be responsible for 0.5–0.7% of the men-
ingitis burden to the entire Dutch population. Due to 
such concerns, numerous product recalls of powdered in-
fant formulae batches in which  C. sakazakii had been de-
tected, even at low numbers, have occurred. Some experts 
and authorities have also recommended the preparation 
of all infant formulae with water heated to at least 70  °  C 
to inactivate live bacteria. However, it is unclear whether 
this measure reduces infection risks in newborn, term or 
older infants if prolonged formula storage is avoided. At 
the same time, preparation of infant formula with water 
heated to at least 70  °  C will definitely reduce its nutrition-
al quality  [42, 44, 45] and increases the risk of scalding 
injuries from hot water which frequently occur in infants 
 [46] .
 Safety concerns due to microbial contamination are 
not limited to commercial infant foods. Human breast 
milk and homemade complementary foods may bear sig-
nificant contamination with microorganisms and afla-
toxins, particularly in low-income countries  [47–50] , 
whereas commercial baby foods generally contain very 
low amounts of mycotoxins  [51] . Aflatoxin contamina-
tion of foods contributes a significant public health bur-
den in low-income countries due to their carcinogenicity 
and their growth-impairing effects in children  [52] .
 Contaminants and Residues 
 European legislation stipulates the absence of appre-
ciable contaminant levels in foodstuffs for particular nu-
tritional uses intended for infants and young children, 
which includes infant and follow-on formulae and com-
mercial baby foods, with a very low common limit for 
pesticide residues of 0.01 mg/kg (1 ppm) considered to be 
close to the minimum detectable level  [3] . Nonetheless, a 
minimal residual risk cannot be excluded with absolute 
certainty. For example, concern has been raised regard-
ing the exposure to endocrine disruptors through infant 
foods with respect to potential impact on health, given 
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that infants are thought to be more sensitive to hormonal 
impacts of environmental chemicals than adults  [53] .
 Exposure to other contaminants must also be consid-
ered. For example, in parenterally fed premature infants, 
aluminum exposure from glassware was related to im-
paired developmental outcomes. In a randomized clini-
cal trial, premature infants exposed for  1 10 days to stan-
dard parenteral feeding solutions had more impaired 
neurologic development at 18 months than infants ran-
domized to solutions especially sourced for low alumini-
um content  [54] . Therefore, it is now recommended to 
limit aluminium exposure of parenterally fed children as 
much as possible, and to avoid the repeated use of calcium 
gluconate in small-volume glass containers for treatment 
in children up to 18 years of age  [54] . Significant alumin-
ium contents have also been found in some infant formu-
lae, including soy protein-based formulae as well as lac-
tose-free, hypoallergenic, and preterm formulae, but it 
remains unknown whether the enteral exposure to these 
aluminium concentrations has any relevant biological ef-
fects  [55, 56] . A recent model calculation estimated that 
the total body burden of aluminium in healthy infants 
from both vaccines and diet throughout the first year of 
life is significantly lower than the corresponding safe 
body burden of aluminium, using the regulatory mini-
mum risk level  [57] .
 Among the contaminants that can be newly formed 
during the production of foodstuffs are furan and acryl-
amide. Furan is formed under heat exposure from carbo-
hydrates, ascorbic acid, and polyunsaturated fatty acids. 
Furan has been classified as a ‘possible human carcino-
gen’ and is found in low concentrations in some baby 
foods  [58, 59] . Acrylamide, another possible carcinogen, 
is formed during heating of starchy foods for longer peri-
ods of time and has been detected in low amounts in in-
fant formulae and commercial baby foods  [60] . Much 
higher concentrations of acrylamide can occur in home-
made and general foods fed to infants and young chil-
dren, who reach much higher exposures than all other 
parts of the population  [61, 62] . The European Commis-
sion has recommended to monitor the content of major 
newly formed contaminants, such as acrylamide and fu-
ran, in food products and to aim at achieving low levels 
whenever possible  [63, 64] . Industry has taken active 
measures to minimize contents of newly formed contam-
inants in food products  [65, 66] .
 In addition to components derived from the raw mate-
rial and the production process of foodstuffs, also pack-
aging materials and feeding devices can add to the expo-
sure to substances with potentially untoward effects. For 
example, the migration of significant amounts of poten-
tially toxic components from baby bottles into feeds, such 
as bisphenol A (BPA), plasticizers, esters, and certain an-
tioxidants, must be avoided  [67–69] . 
 Conclusions 
 The experts attending this workshop emphasized that, 
currently, a very high level of quality and safety in infant 
feeding is achieved but agreed that this was no reason for 
complacency. The public expectation is that infant feed-
ing should be absolutely safe, that is 100% free of any risks 
for or any harm to the baby. However, from a scientific 
perspective an absolute safety cannot be guaranteed, but 
rather one aims at the highest level of risk reduction that 
is achievable, i.e. the approach has to be one of relative 
safety, which is not always an easy concept to explain to 
the public.
 There was agreement that the introduction of new or 
modified infant food products should be preceded by a 
systematic review of the available evidence, and usually 
preclinical safety assessment followed by evaluation in 
clinical trials according to current scientific standards 
 [70–73] . Consumers and health care professionals expect 
any new ingredient to be thoroughly tested by scrupu-
lously conducted clinical trials which usually assess 
growth, monitor adverse events, and are evaluated by the 
appropriate regulatory body (EFSA for Europe, GRAS 
status and FDA in the USA)  [74, 75] . The pediatric par-
ticipants at the workshop agreed that the introduction of 
new or modified infant food products into the market 
should require an evaluation of their suitability and safe-
ty by an independent authority, which at present is the 
case, for example, in the USA and Australia but not in 
Europe  [74, 75] .
 The food industry is expected to use safe and suitable 
ingredients that meet the highest purity standards and 
assume that these are present in the infant foods at levels 
(lower and upper) stipulated by legislation. Control of in-
gredient quality and of good manufacturing practice ap-
pears to be of great importance for ensuring product safe-
ty, and weaknesses regarding these aspects appear to have 
contributed to the frequent recalls and warnings on in-
fant food products that appeared in recent years. Such 
incidents appear to happen mostly because of violation of 
good production process standards and/or insufficient 
control of the supplied ingredients. Moreover, there may 
be considerable pressure to reduce cost of production, 
which could create incentives to compromise on quality. 
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Human error is often found to be the primary cause, but 
the impact of human error can best be minimized by em-
ploying the highest possible quality and safety standards, 
which the industry is encouraged to implement.
 The scientific experts attending this workshop agreed 
that managing food safety events should be done on an 
international basis. Global collaboration of food produc-
ers, food safety authorities, and scientists is needed to ef-
ficiently exchange information and to best protect public 
health.
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